References
- Seow, A, Koh, WP, Chia, KS, Shi, LM, Lee, HP, Shanmugaratnam, K. Trends in cancer incidence in Singapore 1968–2002, Singapore Cancer Registry Report No.6.
- Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA, et al. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallblader carcinoma. Cancer 2004; 101: 578–86
- Hsu C, Chen CN, Chen LT, Wu CY, Yang PM, Lai MY, et al. Low–dose thalidomide treatment for advanced hepatocellular carcinoma. Oncology 2003; 65: 242–9
- Villa E, Ferretti I, Grottola A, Buttafoco P, Buono MG, Giannini F, et al. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. Br J Cancer 2001; 84: 881–5
- Engstrom PF, Levin B, Moertel CG, Schutt A. A phase II trial of tamoxifen in hepatocellular carcinoma. Cancer 1990; 65: 2641–3